Literature DB >> 10636130

Diffusion-weighted MRI in vascular dementia.

S H Choi1, D L Na, C S Chung, K H Lee, D G Na, J C Adair.   

Abstract

OBJECTIVE: To examine the ability of diffusion-weighted MRI (DWI) to detect ongoing cerebral ischemia in patients with vascular dementia (VaD).
BACKGROUND: VaD due to small-vessel disease results from the cumulative impact of recurrent cerebral ischemia. Cerebral ischemia may produce clinical manifestations, producing the "stepwise" decline characteristic of VaD. Conventional MRI can detect small regions of ischemic damage but cannot determine when injury developed. In contrast, DWI shows sensitivity in detecting ischemia of recent onset. DESIGN/
METHODS: Patients with VaD (n = 30) underwent DWI in addition to standard MRI sequences. Patients were divided into two groups according to the presence of new focal deficits or mental change within 10 days before MRI. In 10 patients of positive group, symptomatic neurologic decline occurred an average of 4.2 days before the imaging procedure.
RESULTS: Seven (70%) of 10 patients with a recent neurologic event showed 15 new regions of signal abnormality on DWI. The anatomic distribution of signal change could account for the patients' new symptoms or signs in all but one patient. Similar signal abnormality was detected in 4 (20%) of 20 patients without a recent neurologic event. New foci of altered signal intensity were distinguishable from prior injuries only with DWI. No significant difference was found between patients with and without DWI abnormalities in gender, age, Mini-Mental State Examination score, Hachinski Ischemic Score, vascular risk factors, or severity of increased signal on T2-weighted MRI scans.
CONCLUSION: Small foci of abnormal signal on diffusion-weighted MRI (DWI), presumably representing recent small infarcts, occur often in vascular dementia (VaD) from small-vessel disease, even in patients without a recent "stepwise decline." The results suggest that DWI might be used to monitor VaD progression in future observational and interventional studies of this disorder.

Entities:  

Mesh:

Year:  2000        PMID: 10636130     DOI: 10.1212/wnl.54.1.83

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Diffusion-Weighted Imaging-Detected Ischemic Lesions following Endovascular Treatment of Cerebral Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  K M Bond; W Brinjikji; M H Murad; D F Kallmes; H J Cloft; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-17       Impact factor: 3.825

Review 2.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

3.  Diffusion-weighted MRI for verification of electroporation-based treatments.

Authors:  Faisal Mahmood; Rasmus H Hansen; Birgit Agerholm-Larsen; Kurt S Jensen; Helle K Iversen; Julie Gehl
Journal:  J Membr Biol       Date:  2011-03-06       Impact factor: 1.843

4.  Diffusion-weighted imaging-positive lesions following endovascular treatment for ruptured and unruptured aneurysms: Its incidence according to antithrombotic drugs.

Authors:  Sang Hyuk Lee; Seung Hwan Kim; Ji Hwan Jang; Young Zoon Kim; Kyu Hong Kim; Taek Min Nam
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2022-09-06

5.  Frequency of subclinical lacunar infarcts in ischemic leukoaraiosis and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Michael O'Sullivan; Philip M Rich; Thomas R Barrick; Christopher A Clark; Hugh S Markus
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

Review 6.  Silent cerebral infarcts associated with cardiac disease and procedures.

Authors:  Mariëlla E C Hassell; Robin Nijveldt; Yvo B W Roos; Charles B L Majoie; Martial Hamon; Jan J Piek; Ronak Delewi
Journal:  Nat Rev Cardiol       Date:  2013-10-29       Impact factor: 32.419

7.  Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3.

Authors:  Una Clancy; Daniela Jaime Garcia; Michael S Stringer; Michael J Thrippleton; Maria C Valdés-Hernández; Stewart Wiseman; Olivia Kl Hamilton; Francesca M Chappell; Rosalind Brown; Gordon W Blair; Will Hewins; Emilie Sleight; Lucia Ballerini; Mark E Bastin; Susana Munoz Maniega; Tom MacGillivray; Kirstie Hetherington; Charlene Hamid; Carmen Arteaga; Alasdair G Morgan; Cameron Manning; Ellen Backhouse; Iona Hamilton; Dominic Job; Ian Marshall; Fergus N Doubal; Joanna M Wardlaw
Journal:  Eur Stroke J       Date:  2020-06-05

8.  Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit.

Authors:  Stephanie M Meller; Andreas Baumbach; Szilard Voros; Michael Mullen; Alexandra J Lansky
Journal:  BMC Med       Date:  2013-12-11       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.